Next Article in Journal
The Healing-Promoting Properties of Selected Cyclitols—A Review
Next Article in Special Issue
Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide ([email protected]) Microparticles Improves Oral Bioavailability
Previous Article in Journal
The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
Previous Article in Special Issue
Study of Potential Anti-Inflammatory Effects of Red Wine Extract and Resveratrol through a Modulation of Interleukin-1-Beta in Macrophages

Health Effects of Resveratrol: Results from Human Intervention Trials

Department of Nutrition, Food Science and Gastronomy, School of Pharmacy and Food Sciences XaRTA, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08921 Santa Coloma de Gramenet, Spain
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, Pere Virgili Health Research Center, University Rovira i Virgili, 43201 Reus, Tarragona, Spain
Author to whom correspondence should be addressed.
Nutrients 2018, 10(12), 1892;
Received: 30 October 2018 / Revised: 23 November 2018 / Accepted: 27 November 2018 / Published: 3 December 2018
(This article belongs to the Special Issue Benefits of Resveratrol Supplementation)
The effect of resveratrol (RV) intake has been reviewed in several studies performed in humans with different health status. The purpose of this review is to summarize the results of clinical trials of the last decade, in which RV was determined in biological samples such as human plasma, urine, and feces. The topics covered include RV bioavailability, pharmacokinetics, effects on cardiovascular diseases, cognitive diseases, cancer, type 2 diabetes (T2D), oxidative stress, and inflammation states. The overview of the recent research reveals a clear tendency to identify RV in plasma, showing that its supplementation is safe. Furthermore, RV bioavailability depends on several factors such as dose, associated food matrix, or time of ingestion. Notably, enterohepatic recirculation of RV has been observed, and RV is largely excreted in the urine within the first four hours after consumption. Much of the research on RV in the last 10 years has focused on its effects on pathologies related to oxidative stress, inflammatory biomarkers, T2D, cardiovascular diseases, and neurological diseases. View Full-Text
Keywords: bioavailability; antioxidant; obesity; metabolic diseases bioavailability; antioxidant; obesity; metabolic diseases
Show Figures

Figure 1

MDPI and ACS Style

Ramírez-Garza, S.L.; Laveriano-Santos, E.P.; Marhuenda-Muñoz, M.; Storniolo, C.E.; Tresserra-Rimbau, A.; Vallverdú-Queralt, A.; Lamuela-Raventós, R.M. Health Effects of Resveratrol: Results from Human Intervention Trials. Nutrients 2018, 10, 1892.

AMA Style

Ramírez-Garza SL, Laveriano-Santos EP, Marhuenda-Muñoz M, Storniolo CE, Tresserra-Rimbau A, Vallverdú-Queralt A, Lamuela-Raventós RM. Health Effects of Resveratrol: Results from Human Intervention Trials. Nutrients. 2018; 10(12):1892.

Chicago/Turabian Style

Ramírez-Garza, Sonia L., Emily P. Laveriano-Santos, María Marhuenda-Muñoz, Carolina E. Storniolo, Anna Tresserra-Rimbau, Anna Vallverdú-Queralt, and Rosa M. Lamuela-Raventós 2018. "Health Effects of Resveratrol: Results from Human Intervention Trials" Nutrients 10, no. 12: 1892.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop